Press release content from Business Wire. The AP news staff was not involved in its creation.
European Commission Authorizes COVID-19 Vaccine Moderna in Europe
January 6, 2021 GMT
CAMBRIDGE, Mass. (BUSINESS WIRE) Jan 6, 2021
Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced that the European Commission has granted a conditional marketing authorization (CMA) for COVID-19 Vaccine Moderna, allowing vaccination programs using the Moderna vaccine to be rolled out across the European Union. The authorization is based upon the recommendation of the European Medicines Agency (EMA) for use of the COVID-19 Vaccine Moderna for active immunization to prevent COVID-19 caused by SARS-CoV-2 virus in individuals 18 years of age and older.
Vaccin Pfizer: une personne sur 100 000 est allergique
lessentiel.lu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lessentiel.lu Daily Mail and Mail on Sunday newspapers.
Deux clusters de variant britannique en France
lessentiel.lu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lessentiel.lu Daily Mail and Mail on Sunday newspapers.
L Europe donne son accord pour le vaccin Moderna
lessentiel.lu - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from lessentiel.lu Daily Mail and Mail on Sunday newspapers.